Placebo Control
A review of key issues in pharmaceutical clinical trials
Showing posts with label
Pharmalot
.
Show all posts
Showing posts with label
Pharmalot
.
Show all posts
Wednesday, July 31, 2013
Brazen Scofflaws? Are Pharma Companies Really Completely Ignoring FDAAA?
›
Results reporting requirements are pretty clear. Maybe critics should re-check their methods? Ben Goldacre has rather famously described t...
8 comments:
Wednesday, May 15, 2013
Placebos: Banned in Helsinki?
›
One of the unintended consequences of my (admittedly, somewhat impulsive) decision to name this blog is that I get a fair bit of traffic fr...
2 comments:
Friday, January 25, 2013
Less than Jaw-Dropping: Half of Sites Are Below Average
›
Last week, the Tufts Center for the Study of Drug Development unleashed the latest in their occasional series of dire pronouncements about...
2 comments:
Tuesday, July 24, 2012
How Not to Report Clinical Trial Data: a Clear Example
›
I know it’s not even August yet, but I think we can close the nominations for "Worst Trial Metric of the Year". The hands-down wi...
›
Home
View web version
